NCT04254263 2025-09-11
ATP
RenJi Hospital
Phase 3 Recruiting
Clinical Trials
7 trialsNCT06080620 2023-10-12
The Choice of Treatment Methods and Efficacy of LABC
Peking Union Medical College Hospital
Phase NA Recruiting
NCT03329378 2023-08-22
Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Terminated
NCT05809024 2023-04-12
Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy
Shandong Cancer Hospital and Institute
Phase 4 Recruiting
NCT05749016 2023-03-01
Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT01660542 2016-11-01
An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer
Yonsei University
Phase 4 Completed
NCT00395655 2006-11-03
Hydralazine and Valproate Added to Chemotherapy for Breast Cancer
National Institute of CancerologÃa
Phase 2 Terminated